Arsenic Metabolism in Children Differs From That in Adults

Helena Skröder Löveborn1, Maria Kippler2, Ying Lu1

  • 1*Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SE-171 77, Sweden;

Insights

Children metabolize arsenic more efficiently than adults, with selenium and folate levels significantly influencing this process. Understanding these factors is crucial for mitigating arsenic toxicity risks in pediatric populations.

Area of Science:

  • Environmental Health
  • Toxicology
  • Nutritional Science

Background:

  • Arsenic toxicity in adults is linked to methylation efficiency, affected by gender, genetics, and nutrition.
  • Arsenic metabolism and its influencing factors in children require further investigation.

Purpose of the Study:

  • To evaluate factors influencing arsenic metabolism in children.
  • To compare arsenic metabolism between children and their mothers.

Main Methods:

  • Urinary concentrations of inorganic arsenic (iAs) and its metabolites (MMA, DMA) were measured in 488 children using HPLC-HG-ICPMS.
  • Methylation efficiency was assessed by the relative percentages of urinary arsenic metabolites.
  • Factors evaluated included maternal metabolite patterns, arsenic exposure, gender, socioeconomic status, season, erythrocyte selenium (Ery-Se), plasma folate, and vitamin B12.

Main Results:

  • Children exhibited higher %DMA and lower %iAs compared to mothers, despite lower arsenic exposure.
  • Erythrocyte selenium (Ery-Se) strongly correlated with children's arsenic methylation efficiency, impacting %iAs, %MMA, and %DMA.
  • Plasma folate was inversely associated with %iAs and positively associated with %DMA in children.

Conclusions:

  • Children demonstrate more efficient arsenic methylation than their mothers.
  • Selenium and folate are key nutritional factors influencing arsenic metabolism in children.
  • Differences in influencing factors between children and mothers warrant further research into pediatric arsenic metabolism.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
317
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
314
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310